CLINICAL_TRIALS
trial_result
· 2024-06-20
Clinical Trial Update: Safety and Efficacy Study of TNX-102 SL in Subjects With Military-Related PTSD and Related Conditions [Phase 2]
Summary
Phase 2 safety and efficacy study of TNX-102 SL in military-related post-traumatic stress disorder has completed and posted results on 2024-06-20.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Tonix Pharmaceuticals, Inc. | Conditions: PTSD | Phase 2 | Status: COMPLETED | Results posted: 2024-06-20